-
1
-
-
0034566114
-
Inhibitors of HIV-1 reverse transcriptase
-
Parniak MA, Sluis-Cremer N. Inhibitors of HIV-1 reverse transcriptase. Adv Pharmacol 2000; 49:67-109.
-
(2000)
Adv Pharmacol
, vol.49
, pp. 67-109
-
-
Parniak, M.A.1
Sluis-Cremer, N.2
-
2
-
-
0033770149
-
Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs)
-
Sluis-Cremer N, Arion D, Parniak MA. Molecular mechanisms of HIV-1 resistance to nucleoside reverse transcriptase inhibitors (NRTIs). Cell Mol Life Sci 2000; 57:1408-1422.
-
(2000)
Cell Mol Life Sci
, vol.57
, pp. 1408-1422
-
-
Sluis-Cremer, N.1
Arion, D.2
Parniak, M.A.3
-
3
-
-
0038369038
-
Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues
-
Selmi B, Deval J, Boretto J, Canard B. Nucleotide analogue binding, catalysis and primer unblocking in the mechanisms of HIV-1 reverse transcriptase-mediated resistance to nucleoside analogues. Antivir Ther 2003; 8:143-154.
-
(2003)
Antivir Ther
, vol.8
, pp. 143-154
-
-
Selmi, B.1
Deval, J.2
Boretto, J.3
Canard, B.4
-
4
-
-
3242879168
-
Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues
-
Deval J, Courcambeck J, Selmi B, Boretto J, Canard B. Structural determinants and molecular mechanisms for the resistance of HIV-1 RT to nucleoside analogues. Curr Drug Metab 2004; 5:305-316.
-
(2004)
Curr Drug Metab
, vol.5
, pp. 305-316
-
-
Deval, J.1
Courcambeck, J.2
Selmi, B.3
Boretto, J.4
Canard, B.5
-
5
-
-
0032506055
-
Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): Increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase
-
Arion D, Kaushik N, McCormick S, Borkow G, Parniak MA. Phenotypic mechanism of HIV-1 resistance to 3′-azido-3′-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase. Biochemistry 1998; 37:15908-15917.
-
(1998)
Biochemistry
, vol.37
, pp. 15908-15917
-
-
Arion, D.1
Kaushik, N.2
McCormick, S.3
Borkow, G.4
Parniak, M.A.5
-
6
-
-
0033165851
-
A mechanism of AZT resistance: An increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase
-
Meyer PR, Matsuura SE, Mian AM, So AG, Scott WA. A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase. Mol Cell 1999; 4:35-43.
-
(1999)
Mol Cell
, vol.4
, pp. 35-43
-
-
Meyer, P.R.1
Matsuura, S.E.2
Mian, A.M.3
So, A.G.4
Scott, W.A.5
-
7
-
-
0035031936
-
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase
-
Boyer PL, Sarafianos SG, Arnold E, Hughes SH. Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol 2001; 75:4832-4842.
-
(2001)
J Virol
, vol.75
, pp. 4832-4842
-
-
Boyer, P.L.1
Sarafianos, S.G.2
Arnold, E.3
Hughes, S.H.4
-
8
-
-
0033587620
-
Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase
-
Feng JY, Anderson KS. Mechanistic studies examining the efficiency and fidelity of DNA synthesis by the 3TC-resistant mutant (184V) of HIV-1 reverse transcriptase. Biochemistry 1999; 38:9440-9448.
-
(1999)
Biochemistry
, vol.38
, pp. 9440-9448
-
-
Feng, J.Y.1
Anderson, K.S.2
-
9
-
-
0035930584
-
Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue
-
Selmi B, Boretto J, Sarfati SR, Guerreiro C, Canard B. Mechanism-based suppression of dideoxynucleotide resistance by K65R human immunodeficiency virus reverse transcriptase using an alpha-boranophosphate nucleoside analogue. J Biol Chem 2001; 276:48466-48472.
-
(2001)
J Biol Chem
, vol.276
, pp. 48466-48472
-
-
Selmi, B.1
Boretto, J.2
Sarfati, S.R.3
Guerreiro, C.4
Canard, B.5
-
10
-
-
0036829992
-
The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues
-
Deval J, Selmi B, Boretto J, Egloff MP, Guerreiro C, Sarfati S, Canard B. The molecular mechanism of multidrug resistance by the Q151M human immunodeficiency virus type 1 reverse transcriptase and its suppression using alpha-boranophosphate nucleotide analogues. J Biol Chem 2002; 277:42097-42104.
-
(2002)
J Biol Chem
, vol.277
, pp. 42097-42104
-
-
Deval, J.1
Selmi, B.2
Boretto, J.3
Egloff, M.P.4
Guerreiro, C.5
Sarfati, S.6
Canard, B.7
-
11
-
-
0347052875
-
Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations
-
Deval J, White KL, Miller MD, Parkin NT, Courcambeck J, Halfon P, et al. Mechanistic basis for reduced viral and enzymatic fitness of HIV-1 reverse transcriptase containing both K65R and M184V mutations. J Biol Chem 2004; 279:509-516.
-
(2004)
J Biol Chem
, vol.279
, pp. 509-516
-
-
Deval, J.1
White, K.L.2
Miller, M.D.3
Parkin, N.T.4
Courcambeck, J.5
Halfon, P.6
-
12
-
-
2942616457
-
A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions
-
Deval J, Navarro JM, Selmi B, Courcambeck J, Boretto J, Halfon P, et al. A loss of viral replicative capacity correlates with altered DNA polymerization kinetics by the human immunodeficiency virus reverse transcriptase bearing the K65R and L74V dideoxynucleoside resistance substitutions. J Biol Chem 2004; 279:25489-25496.
-
(2004)
J Biol Chem
, vol.279
, pp. 25489-25496
-
-
Deval, J.1
Navarro, J.M.2
Selmi, B.3
Courcambeck, J.4
Boretto, J.5
Halfon, P.6
-
13
-
-
0034947293
-
Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: Analysis of enzyme processivity, chain-terminator removal and viral replication
-
Naeger LK, Margot NA, Miller MD. Increased drug susceptibility of HIV-1 reverse transcriptase mutants containing M184V and zidovudine-associated mutations: analysis of enzyme processivity, chain-terminator removal and viral replication. Antivir Ther 2001; 6:115-126.
-
(2001)
Antivir Ther
, vol.6
, pp. 115-126
-
-
Naeger, L.K.1
Margot, N.A.2
Miller, M.D.3
-
14
-
-
0036124432
-
The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1
-
Boyer PL, Sarafianos SG, Arnold E, Hughes SH. The M184V mutation reduces the selective excision of zidovudine 5′-monophosphate (AZTMP) by the reverse transcriptase of human immunodeficiency virus type 1. J Virol 2002; 76:3248-3256.
-
(2002)
J Virol
, vol.76
, pp. 3248-3256
-
-
Boyer, P.L.1
Sarafianos, S.G.2
Arnold, E.3
Hughes, S.H.4
-
15
-
-
21444452131
-
The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations
-
Miranda LR, Gotte M, Liang F, Kuritzkes DR. The L74V mutation in human immunodeficiency virus type 1 reverse transcriptase counteracts enhanced excision of zidovudine monophosphate associated with thymidine analog resistance mutations. Antimicrob Agents Chemother 2005; 49:2648-2656.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2648-2656
-
-
Miranda, L.R.1
Gotte, M.2
Liang, F.3
Kuritzkes, D.R.4
-
16
-
-
33645500469
-
The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations
-
White KL, Chen JM, Feng JY, Margot NA, Ly JK, Ray AS, et al. The K65R reverse transcriptase mutation in HIV-1 reverses the excision phenotype of zidovudine resistance mutations. Antivir Ther 2006; 11:155-163.
-
(2006)
Antivir Ther
, vol.11
, pp. 155-163
-
-
White, K.L.1
Chen, J.M.2
Feng, J.Y.3
Margot, N.A.4
Ly, J.K.5
Ray, A.S.6
-
17
-
-
0029028067
-
Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy
-
Larder BA, Kemp SD, Harrigan PR. Potential mechanism for sustained antiretroviral efficacy of AZT-3TC combination therapy. Science 1995; 269:696-699.
-
(1995)
Science
, vol.269
, pp. 696-699
-
-
Larder, B.A.1
Kemp, S.D.2
Harrigan, P.R.3
-
18
-
-
0028273314
-
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations
-
Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, et al. Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis 1994; 169:722-729.
-
(1994)
J Infect Dis
, vol.169
, pp. 722-729
-
-
Shafer, R.W.1
Kozal, M.J.2
Winters, M.A.3
Iversen, A.K.4
Katzenstein, D.A.5
Ragni, M.V.6
-
19
-
-
0036897074
-
Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine
-
Stoeckli TC, MaWhinney S, Uy J, Duan C, Lu J, Shugarts D, Kuritzkes DR. Phenotypic and genotypic analysis of biologically cloned human immunodeficiency virus type 1 isolates from patients treated with zidovudine and lamivudine. Antimicrob Agents Chemother 2002; 46:4000-4003.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 4000-4003
-
-
Stoeckli, T.C.1
MaWhinney, S.2
Uy, J.3
Duan, C.4
Lu, J.5
Shugarts, D.6
Kuritzkes, D.R.7
-
20
-
-
14744267571
-
In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase
-
Parikh UM, Koontz DL, Chu CK, Schinazi RF, Mellors JW. In vitro activity of structurally diverse nucleoside analogs against human immunodeficiency virus type 1 with the K65R mutation in reverse transcriptase. Antimicrob Agents Chemother 2005; 49:1139-1144.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 1139-1144
-
-
Parikh, U.M.1
Koontz, D.L.2
Chu, C.K.3
Schinazi, R.F.4
Mellors, J.W.5
-
21
-
-
0037131342
-
The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients
-
Winston A, Mandalia S, Pillay D, Gazzard B, Pozniak A. The prevalence and determinants of the K65R mutation in HIV-1 reverse transcriptase in tenofovir-naive patients. AIDS 2002; 16:2087-2089.
-
(2002)
AIDS
, vol.16
, pp. 2087-2089
-
-
Winston, A.1
Mandalia, S.2
Pillay, D.3
Gazzard, B.4
Pozniak, A.5
-
22
-
-
33646440592
-
The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations
-
Parikh UM, Bacheler L, Koontz D, Mellors JW. The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations. J Virol 2006; 80:4971-4977.
-
(2006)
J Virol
, vol.80
, pp. 4971-4977
-
-
Parikh, U.M.1
Bacheler, L.2
Koontz, D.3
Mellors, J.W.4
-
23
-
-
2342661255
-
K65R, TAMs and tenofovir
-
Miller MD. K65R, TAMs and tenofovir. AIDS Rev 2004; 6:22-33.
-
(2004)
AIDS Rev
, vol.6
, pp. 22-33
-
-
Miller, M.D.1
-
24
-
-
7744219542
-
Predictors of selection of K65R: Tenofovir use and lack of thymidine analogue mutations
-
Valer L, Martin-Carbonero L, deMendoza C, Corral A, Soriano V. Predictors of selection of K65R: tenofovir use and lack of thymidine analogue mutations. AIDS 2004; 18:2094-2096.
-
(2004)
AIDS
, vol.18
, pp. 2094-2096
-
-
Valer, L.1
Martin-Carbonero, L.2
deMendoza, C.3
Corral, A.4
Soriano, V.5
-
25
-
-
11844255339
-
Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1
-
Segondy M, Montes B. Prevalence and conditions of selection of the K65R mutation in the reverse transcriptase gene of HIV-1. J Acquir Immune Defic Syndr 2005; 38:110-111.
-
(2005)
J Acquir Immune Defic Syndr
, vol.38
, pp. 110-111
-
-
Segondy, M.1
Montes, B.2
-
26
-
-
20044390947
-
Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients
-
Wirden M, Marcelin AG, Simon A, Kirstetter M, Tubiana R, Valantin MA, et al. Resistance mutations before and after tenofovir regimen failure in HIV-1 infected patients. J Med Virol 2005; 76:297-301.
-
(2005)
J Med Virol
, vol.76
, pp. 297-301
-
-
Wirden, M.1
Marcelin, A.G.2
Simon, A.3
Kirstetter, M.4
Tubiana, R.5
Valantin, M.A.6
-
27
-
-
33748052358
-
Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level
-
Parikh UM, Barnas DC, Faruki H, Mellors JW. Antagonism between the HIV-1 reverse-transcriptase mutation K65R and thymidine-analogue mutations at the genomic level. J Infect Dis 2006; 194:651-660.
-
(2006)
J Infect Dis
, vol.194
, pp. 651-660
-
-
Parikh, U.M.1
Barnas, D.C.2
Faruki, H.3
Mellors, J.W.4
-
28
-
-
0025191211
-
Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography
-
Le Grice SF, Gruninger-Leitch F. Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. Eur J Biochem 1990; 187:307-314.
-
(1990)
Eur J Biochem
, vol.187
, pp. 307-314
-
-
Le Grice, S.F.1
Gruninger-Leitch, F.2
-
29
-
-
0028789990
-
Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase
-
Le Grice SF, Cameron CE, Benkovic SJ. Purification and characterization of human immunodeficiency virus type 1 reverse transcriptase. Methods Enzymol 1995; 262:130-144.
-
(1995)
Methods Enzymol
, vol.262
, pp. 130-144
-
-
Le Grice, S.F.1
Cameron, C.E.2
Benkovic, S.J.3
-
31
-
-
23844479950
-
The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1
-
Sluis-Cremer N, Arion D, Parikh U, Koontz D, Schinazi RF, Mellors JW, Parniak MA. The 3′-azido group is not the primary determinant of 3′-azido-3′-deoxythymidine (AZT) responsible for the excision phenotype of AZT-resistant HIV-1. J Biol Chem 2005; 280:29047-29052.
-
(2005)
J Biol Chem
, vol.280
, pp. 29047-29052
-
-
Sluis-Cremer, N.1
Arion, D.2
Parikh, U.3
Koontz, D.4
Schinazi, R.F.5
Mellors, J.W.6
Parniak, M.A.7
-
32
-
-
0034737638
-
Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′- deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase
-
Arion D, Sluis-Cremer N, Parniak MA. Mechanism by which phosphonoformic acid resistance mutations restore 3′-azido-3′- deoxythymidine (AZT) sensitivity to AZT-resistant HIV-1 reverse transcriptase. J Biol Chem 2000; 275:9251-9255.
-
(2000)
J Biol Chem
, vol.275
, pp. 9251-9255
-
-
Arion, D.1
Sluis-Cremer, N.2
Parniak, M.A.3
-
33
-
-
22244458608
-
Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5(-O-1-thiotriphosphate
-
E-pub 3 June
-
Radzio J, Sluis-Cremer N. Stereo-selectivity of HIV-1 reverse transcriptase toward isomers of thymidine-5(-O-1-thiotriphosphate. Protein Sci 2005; 14:1929-1933; E-pub 3 June 2005.
-
(2005)
Protein Sci 2005
, vol.14
, pp. 1929-1933
-
-
Radzio, J.1
Sluis-Cremer, N.2
-
34
-
-
0028916224
-
Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates
-
Johnson KA. Rapid quench kinetic analysis of polymerases, adenosinetriphosphatases, and enzyme intermediates. Methods Enzymol 1995; 249:38-61.
-
(1995)
Methods Enzymol
, vol.249
, pp. 38-61
-
-
Johnson, K.A.1
-
35
-
-
0142042463
-
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates
-
Whitcomb JM, Parkin NT, Chappey C, Hellmann NS, Petropoulos CJ. Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates. J Infect Dis 2003; 188:992-1000.
-
(2003)
J Infect Dis
, vol.188
, pp. 992-1000
-
-
Whitcomb, J.M.1
Parkin, N.T.2
Chappey, C.3
Hellmann, N.S.4
Petropoulos, C.J.5
-
36
-
-
27544431950
-
A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT
-
White KL, Margot NA, Ly JK, Chen JM, Ray AS, Pavelko M, et al. A combination of decreased NRTI incorporation and decreased excision determines the resistance profile of HIV-1 K65R RT. AIDS 2005; 19:1751-1760.
-
(2005)
AIDS
, vol.19
, pp. 1751-1760
-
-
White, K.L.1
Margot, N.A.2
Ly, J.K.3
Chen, J.M.4
Ray, A.S.5
Pavelko, M.6
-
37
-
-
0042347690
-
Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis
-
Ray AS, Murakami E, Basavapathruni A, Vaccaro JA, Ulrich D, Chu CK, et al. Probing the molecular mechanisms of AZT drug resistance mediated by HIV-1 reverse transcriptase using a transient kinetic analysis. Biochemistry 2003; 42:8831-8841.
-
(2003)
Biochemistry
, vol.42
, pp. 8831-8841
-
-
Ray, A.S.1
Murakami, E.2
Basavapathruni, A.3
Vaccaro, J.A.4
Ulrich, D.5
Chu, C.K.6
-
38
-
-
0142100752
-
The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis
-
Gotte M, Arion D, Parniak MA, Wainberg MA. The M184V mutation in the reverse transcriptase of human immunodeficiency virus type 1 impairs rescue of chain-terminated DNA synthesis. J Virol 2000; 74:3579-3585.
-
(2000)
J Virol
, vol.74
, pp. 3579-3585
-
-
Gotte, M.1
Arion, D.2
Parniak, M.A.3
Wainberg, M.A.4
-
39
-
-
21444443785
-
Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase
-
Frankel FA, Marchand B, Turner D, Gotte M, Wainberg MA. Impaired rescue of chain-terminated DNA synthesis associated with the L74V mutation in human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 2005; 49:2657-2664.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 2657-2664
-
-
Frankel, F.A.1
Marchand, B.2
Turner, D.3
Gotte, M.4
Wainberg, M.A.5
-
40
-
-
2342453265
-
Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir
-
Tuske S, Sarafianos SG, Clark AD Jr, Ding J, Naeger LK, White KL, et al. Structures of HIV-1 RT-DNA complexes before and after incorporation of the anti-AIDS drug tenofovir. Nat Struct Mol Biol 2004; 11:469-474.
-
(2004)
Nat Struct Mol Biol
, vol.11
, pp. 469-474
-
-
Tuske, S.1
Sarafianos, S.G.2
Clark Jr, A.D.3
Ding, J.4
Naeger, L.K.5
White, K.L.6
-
41
-
-
0032573488
-
Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: Implications for drug resistance
-
Huang H, Chopra R, Verdine GL, Harrison SC. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance. Science 1998; 282:1669-1675.
-
(1998)
Science
, vol.282
, pp. 1669-1675
-
-
Huang, H.1
Chopra, R.2
Verdine, G.L.3
Harrison, S.C.4
-
42
-
-
0034657706
-
Mutational analysis of Lys65 of HIV-1 reverse transcriptase
-
Sluis-Cremer N, Arion D, Kaushik N, Lim H, Parniak MA. Mutational analysis of Lys65 of HIV-1 reverse transcriptase. Biochem J 2000; 348:77-82.
-
(2000)
Biochem J
, vol.348
, pp. 77-82
-
-
Sluis-Cremer, N.1
Arion, D.2
Kaushik, N.3
Lim, H.4
Parniak, M.A.5
-
43
-
-
0031925680
-
A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2′,3′-dideoxy-3′-thiacytidine
-
Kemp SD, Shi C, Bloor S, Harrigan PR, Mellors JW, Larder BA. A novel polymorphism at codon 333 of human immunodeficiency virus type 1 reverse transcriptase can facilitate dual resistance to zidovudine and L-2′,3′-dideoxy-3′-thiacytidine. J Virol 1998; 72:5093-5098.
-
(1998)
J Virol
, vol.72
, pp. 5093-5098
-
-
Kemp, S.D.1
Shi, C.2
Bloor, S.3
Harrigan, P.R.4
Mellors, J.W.5
Larder, B.A.6
|